[

adar poonawalla

]
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India.(Reuters)

Please be patient: SII’s Poonawalla asks nations waiting for Covishield supplies

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON FEB 21, 2021 12:03 PM IST
  • Till February 8, India has exported Covid-19 vaccines worth 338 crore, Union minister Piyush Goyal had informed Parliament during the Budget Session earlier this month.
Close
India’s vaccine delivery is expected to bring some optimism to the ties between the two countries which witnessed friction after Trudeau, in December 2020, conveyed his support to the ongoing farmers’ protest in Delhi.(Reuters)
India’s vaccine delivery is expected to bring some optimism to the ties between the two countries which witnessed friction after Trudeau, in December 2020, conveyed his support to the ongoing farmers’ protest in Delhi.(Reuters)

‘I’m on it’: SII’s Adar Poonawalla assures Covid-19 vaccine supply to Canada

By hindustantimes.com | Written by Srivatsan K C, Hindustan Times, New Delhi
UPDATED ON FEB 15, 2021 02:44 PM IST
Prime Minister Narendra Modi had assured Covid-19 vaccine supplies sought by Canada in a call with PM Trudeau.
Close
Adar Poonawalla visited a vaccination centre in Pune on Friday.
Adar Poonawalla visited a vaccination centre in Pune on Friday.

'Rapid pace of vaccination,' tweets Adar Poonawalla after visiting Pune centre

By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON FEB 13, 2021 01:35 PM IST
'What an excellent setup,' Poonawalla said as he praised health ministry's arrangement of vaccine roll-out in the country.
Close
The ad shared by Anand Mahindra may tickle your funny bone too.(Twitter/@anandmahindra)
The ad shared by Anand Mahindra may tickle your funny bone too.(Twitter/@anandmahindra)

Anand Mahindra’s share regarding Covid vaccine is a hit among netizens

By Srimoyee Chowdhury
UPDATED ON FEB 12, 2021 01:02 AM IST
Thinking about what to gift your loved one on Valentine's Day? Anand Mahindra has the answer.
Close
Adar Poonawalla, the director of Rising Sun, has said he sees unlimited potential in the financial services space in the country and the proposed deal only helping widen the same. (Bloomberg)
Adar Poonawalla, the director of Rising Sun, has said he sees unlimited potential in the financial services space in the country and the proposed deal only helping widen the same. (Bloomberg)

Adar Poonawalla to buy Magma Fincorp. Here’s all about the deal

By hindustantimes.com | Written by Meenakshi Ray
PUBLISHED ON FEB 11, 2021 07:53 PM IST
The Pune-based Poonawalla Group has said it is acquiring a controlling 60 per cent stake in Magma Fincorp by subscribing to a 3,456-crore preferential issue.
Close
“There’s a huge void we saw with certain other non-bank finance companies going belly up and that has given space for new entrants to come in,” Adar Poonawalla said in an interview with ET Now television.(Shankar Narayan/HT Photo)
“There’s a huge void we saw with certain other non-bank finance companies going belly up and that has given space for new entrants to come in,” Adar Poonawalla said in an interview with ET Now television.(Shankar Narayan/HT Photo)

Vaccine billionaire Adar Poonawalla's buyout of Indian shadow bank boosts stock

Bloomberg
PUBLISHED ON FEB 11, 2021 07:33 PM IST
Adar Poonawalla is expanding his shadow banking business just as the industry is showing signs of recovery following a crisis that started with the collapse of a non-bank financier in 2018. The pandemic had made it harder for small shadow lenders such as Magma Fincorp to raise money.
Close
Talking about the visit, the Member of Parliament from South West Norfolk had earlier told Livemint that SII will produce more than a billion doses of the UK developed Oxford vaccine, helping to save lives in the country and beyond
Talking about the visit, the Member of Parliament from South West Norfolk had earlier told Livemint that SII will produce more than a billion doses of the UK developed Oxford vaccine, helping to save lives in the country and beyond

UK delegation visits Serum institute, talks held on enhancing relationship

By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi
PUBLISHED ON FEB 08, 2021 05:09 PM IST
  • Elizabeth Truss is on a four-day visit to India for talks with Piyush Goyal towards an “enhanced trade partnership”. After concluding her visit to the facility at Pune, Truss tweeted that SII will also be producing 1.3 billion doses for the COVAX alliance to which UK has committed £548 million.
Close
Workers transfer carton boxes of a Covishield vaccine developed by Pune based Serum Institute of India (SII) that arrived in a truck into the Karnataka Health Department cold storage facility in Bangalore. (AFP)
Workers transfer carton boxes of a Covishield vaccine developed by Pune based Serum Institute of India (SII) that arrived in a truck into the Karnataka Health Department cold storage facility in Bangalore. (AFP)

SII to supply 1.1 billion doses of Covid-19 vaccines to Covax vaccine scheme

Reuters, Geneva/london
PUBLISHED ON FEB 03, 2021 07:45 PM IST
UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.
Close
Security personnel stand guard outside Wistron Infocomm Manufacturing India Pvt Ltd, where a section of workers went on a rampage at its facility manufacturing Apple iPhones and other products over non-payment of promised wage, at Narasapura area in Bengaluru, Sunday, Dec. 13, 2020.(PTI)
Security personnel stand guard outside Wistron Infocomm Manufacturing India Pvt Ltd, where a section of workers went on a rampage at its facility manufacturing Apple iPhones and other products over non-payment of promised wage, at Narasapura area in Bengaluru, Sunday, Dec. 13, 2020.(PTI)

Industry captains welcome hike in public spending

By Ishita Guha
PUBLISHED ON FEB 02, 2021 12:33 AM IST
“The government, through the budget, has clearly indicated that it is willing to spend to stimulate growth even if it means higher fiscal deficit,” said Uday Kotak, executive vice chairman and managing director of Kotak Mahindra Bank Ltd.
Close
SII has applied to India’s drugs controller for permission to conduct a small bridging study for Novavax’s Covid-19 vaccine candidate.(Reuters)
SII has applied to India’s drugs controller for permission to conduct a small bridging study for Novavax’s Covid-19 vaccine candidate.(Reuters)

Now, SII seeks trial approval for Novavax Covid vaccine

By Rhythma Kaul, New Delhi
PUBLISHED ON JAN 31, 2021 04:14 AM IST
SII is currently manufacturing Covishield, which has been developed by the University of Oxford and AstraZeneca and is one of the two coronavirus vaccines approved in the country.
Close
Serum Institute of India's (SII's) chief executive officer Adar Poonawalla said on Saturday his company is hopeful of launching Covovax by June 2021.(Shankar Narayan/HT Photo)
Serum Institute of India's (SII's) chief executive officer Adar Poonawalla said on Saturday his company is hopeful of launching Covovax by June 2021.(Shankar Narayan/HT Photo)

News updates from HT: SII hopeful of launching Covavax by June 2021

By hindustantimes.com, Hindustan Times, New Delhi
PUBLISHED ON JAN 30, 2021 04:51 PM IST
  • Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
Close
Indian Railway Catering and Tourism Corporation (IRCTC) on Friday announced it will resume its e-catering services from next month(PTI)
Indian Railway Catering and Tourism Corporation (IRCTC) on Friday announced it will resume its e-catering services from next month(PTI)

News updates from HT: IRCTC to resume e-catering services from Feb

By hindustantimes.com, Hindustan Times, New Delhi
UPDATED ON JAN 22, 2021 08:52 PM IST
Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
Close
Maharashtra Chief Minister Uddhav Thackeray, tourism and environment Minister Aditya Thackeray along with Serum Institute of India CEO Adar Poonawalla at the site of fire on Friday, (ANI)
Maharashtra Chief Minister Uddhav Thackeray, tourism and environment Minister Aditya Thackeray along with Serum Institute of India CEO Adar Poonawalla at the site of fire on Friday, (ANI)

'No angle ruled out yet': What we know so far on Serum Institute fire

Written by Poulomi Ghosh
UPDATED ON JAN 22, 2021 07:45 PM IST
United Nations Secretary-General Antonio Guterres expressed grief over the fire incident.
Close
Maharashtra Chief Minister Uddhav Thackeray speaks as he attends a meeting through video conferencing in Mumbai. (ANI Photo)
Maharashtra Chief Minister Uddhav Thackeray speaks as he attends a meeting through video conferencing in Mumbai. (ANI Photo)

SII fire accident or sabotage to be known after probe, says Uddhav Thackeray

PTI
PUBLISHED ON JAN 22, 2021 06:15 PM IST
Five men died in the fire that broke out in a five- storeyed under-construction building in the SII's Manjari premises in Pune on Thursday.
Close
On January 16, 2021, the first dose of the Covishield vaccine was administered to recipients based on a priority list prepared by the government.(Bloomberg)
On January 16, 2021, the first dose of the Covishield vaccine was administered to recipients based on a priority list prepared by the government.(Bloomberg)

Covishield: A timeline of the Covid-19 vaccine manufactured by SII

By hindustantimes.com | Written by Srivatsan K C
UPDATED ON JAN 16, 2021 11:21 PM IST
Pune-based Serum Institute of India partnered with the Oxford University to manufacture their Covishield vaccine in India.
Close
FILE PHOTO: Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas/File Photo(REUTERS)
FILE PHOTO: Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas/File Photo(REUTERS)

Serum Institute’s Adar Poonawalla takes Covishield vaccine, congratulates PM

By HT Correspondent | Edited by Abhinav Sahay, Pune
PUBLISHED ON JAN 16, 2021 02:27 PM IST
  • The SII also plans to export Covishield doses to Brazil in the coming days.
Close
The gravity of the moment dawned upon the drivers of the trucks as the crowd present at the gates erupted in spontaneous applause that pierced the silence of the morning
The gravity of the moment dawned upon the drivers of the trucks as the crowd present at the gates erupted in spontaneous applause that pierced the silence of the morning

As vaccine trucks leave Serum campus, India starts fight to end Covid in country

By Shalaka Shinde, Steffy Thevar, Pune
UPDATED ON JAN 12, 2021 10:44 PM IST
At the stroke of 4:53 am, the gates opened, a police escort van remerged; it was followed by three trucks, with boxes carrying 5.65 million doses of the vaccine meant for Delhi, Chennai, Ahmedabad, Hyderabad, Chandigarh, Kolkata, Patna, Bengaluru, and Lucknow.
Close
Representational image.(AFP)
Representational image.(AFP)

Serum Institute, Bharat Biotech pledge smooth Covid-19 vaccine roll-out

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 05:03 PM IST
Both the vaccine makers on Tuesday communicated their combined intent to develop, manufacture and supply Covid-19 vaccines
Close
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India, on Wednesday tweeted clarifying that SII is allowed to export its vaccines.(REUTERS)
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India, on Wednesday tweeted clarifying that SII is allowed to export its vaccines.(REUTERS)

Exports of Covishield allowed to all countries, clarifies Adar Poonawalla

By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 03:08 PM IST
Bharat Biotech and Serum Institute of India will issue a joint statement to clarify a few points as since Sunday the two vaccine makers appear to be at loggerheads.
Close
A volunteer being vaccinated by a medic during the Bharat Biotech’s ‘Covaxin’ human trial in Jaipur.(PTI)
A volunteer being vaccinated by a medic during the Bharat Biotech’s ‘Covaxin’ human trial in Jaipur.(PTI)

Sparks fly over ‘water’: Covaxin hits out at critics, says trials 200% honest

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 05:34 AM IST
Experts pointed out that the government may have acted in haste, and the sentiment was echoed by some Opposition politicians who suggested that the Union government ignored scientific protocols to give the nod to a fully indigenous vaccine because it tied in with the Atmanirbhar Bharat slogan.
Close
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture inside his office at the Serum Institute of India, in Pune.(REUTERS)
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture inside his office at the Serum Institute of India, in Pune.(REUTERS)

Covishield vaccine to be sold to govt at Rs 200/ dose, higher price for private buyers, says Adar Poonawalla

By Associated Press | Posted by Arpan Rai | New Delhi
UPDATED ON JAN 04, 2021 09:56 AM IST
With rich nations reserving most of the vaccines that will be made this year, Serum Institute — the world’s largest vaccine manufacturer — is likely to make most of the inoculations for developing countries.
Close
Adar Poonawalla, chief executive officer (CEO) of the Serum Institute of India at the Serum Institute of India, Pune, India.(Reuters)
Adar Poonawalla, chief executive officer (CEO) of the Serum Institute of India at the Serum Institute of India, Pune, India.(Reuters)

‘Can deliver vaccines 7-10 days after purchase order’: Adar Poonawalla

By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON JAN 04, 2021 05:48 AM IST
“We wanted the drugs controller and the ministry of health to really go through all the data, examine everything, to double check what we have done, what Oxford has done that is safe and effective,” Adar Poonawalla, CEO of SII.
Close
Dose of the Oxford University/AstraZeneca Covid-19 vaccine is displayed from its box at the Princess Royal Hospital in Haywards Heath, West Sussex, Britain on January 2, 2021.(Reuters File Photo)
Dose of the Oxford University/AstraZeneca Covid-19 vaccine is displayed from its box at the Princess Royal Hospital in Haywards Heath, West Sussex, Britain on January 2, 2021.(Reuters File Photo)

SII to meet local demand for Oxford vaccine for next 2 months, before exporting

By Reuters | Posted by Kanishka Sarkar | New Delhi
PUBLISHED ON JAN 03, 2021 09:13 PM IST
SII is still waiting to strike a formal supply deal with the government, but is expected to do so in the coming days.
Close
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India, thanked all stakeholders after Covishield got final nod in India.(REUTERS)
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India, thanked all stakeholders after Covishield got final nod in India.(REUTERS)

‘Finally paid off’: Adar Poonawalla thanks PM Modi, DCGI after Covishield gets final approval

By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON JAN 03, 2021 08:29 PM IST
Even before getting the approval from the apex drug controller of India, Serum Institute of India stockpiled about 40-50 million doses of the Covid-19 vaccine, taking a major risk.
Close
A view showing the campus of Delhi's first Covid-19 vaccination centre set up in Srinivaspuri, New Delhi, India.(Amal KS/HT PHOTO)
A view showing the campus of Delhi's first Covid-19 vaccination centre set up in Srinivaspuri, New Delhi, India.(Amal KS/HT PHOTO)

Why India could catch up quickly on Covid vaccination

By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON JAN 02, 2021 04:58 AM IST
With the manufacturing and stockpiling license, the Serum Institute of India has already been able to stockpile 75 million doses of the Oxford/AstraZeneca vaccine and by the first week of January, we will have 100 million doses.
Close
A healthcare worker make preparations inside a room at a vaccination center set up at a South Delhi Municipal Corp. maternity home ahead of a nationwide trial of a Covid-19 vaccine delivery system in New Delhi, India.(Bloomberg)
A healthcare worker make preparations inside a room at a vaccination center set up at a South Delhi Municipal Corp. maternity home ahead of a nationwide trial of a Covid-19 vaccine delivery system in New Delhi, India.(Bloomberg)

Happy Vaccine Year

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 02, 2021 04:32 AM IST
An SII official said on Thursday at a webinar that the company had already stockpiled 75 million doses. SII’s chief executive Adar Poonawalla on Wednesday said the company will be supplying India and Covax in a 50-50 manner as and when it produces vials.
Close
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune.(REUTERS)
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune.(REUTERS)

Nod for emergency use authorisation expected in a few days: SII’s Adar Poonawalla

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON DEC 29, 2020 04:26 AM IST
The Pune-based vaccine maker’s CEO Adar Poonawalla said separately on Monday that approvals were expected in a few days,
Close
Men walk past a mural of frontline workers amid the spread of the coronavirus disease in Mumbai, India.(REUTERS)
Men walk past a mural of frontline workers amid the spread of the coronavirus disease in Mumbai, India.(REUTERS)

‘300 million doses by July’: SII chief Adar Poonawalla on Covishield

By hindustantimes.com | Edited by Arpan Rai | Hindustan Times, New Delhi
UPDATED ON DEC 28, 2020 08:05 PM IST
Hinting at approval from British and Indian governments to approve shots for emergency use, Poonawalla said, “You will be hearing some good news from the UK very soon.”
Close
Serum Institute of India (SII) chief executive officer Adar Poonawalla is seen in Pune in this file photo.(Shankar Narayan/HT Photo)
Serum Institute of India (SII) chief executive officer Adar Poonawalla is seen in Pune in this file photo.(Shankar Narayan/HT Photo)

Govt must protect vaccine makers against lawsuits: SII’s Adar Poonawalla

By hindustantimes.com | Edited by Meenakshi Ray | Hindustan Times, New Delhi
UPDATED ON DEC 19, 2020 10:29 AM IST
The government, Adar Poonawalla said, should bring a law as it would help companies focus on developing and manufacturing the vaccines rather than having to address legal issues.
Close
Adar Poonawalla hopes SII will get emergency-use authorisation of its vaccine candidate by December. (HT Photo)
Adar Poonawalla hopes SII will get emergency-use authorisation of its vaccine candidate by December. (HT Photo)

Vaccination drive in India may start in January, says Adar Poonawalla as Serum Institute hopes to get nod by December

By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON DEC 12, 2020 01:58 PM IST
Pune’s SII is preparing to manufacture enough vaccines for the government as well as private makers.
Close
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved